Mindset
Mindset, licence 80083048: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Mindset V. 2
- Licence holder
- Fusion Nutrition Inc.
- NPN or DIN-HM
- 80083048
- Status
- Active licence
- Licence date
- 12 February 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 24.69 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 24.69 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lévocarnitine Source : L-tartrate de carnitine | 366.85 milligramme | Not calculated |
| Acide L-aspartique Source : Acide L-aspartique | 250.0 milligramme | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 66.6 milligramme | Not calculated |
| Calcium Source : Carbonate de calcium | 15.0 milligramme | 45,000 µg |
| Magnésium Source : Oxyde de magnésium | 19.8 milligramme | 59,400 µg |
| L-théanine Source : L-Théanine | 83.33 milligramme | Not calculated |
| Rhodiola rosea Source : Racine Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 2500 milligramme Potency : 1.0 % Rosavins | 50.0 milligramme | Not calculated |
| Rhodiola rosea Source : Racine Potency : 3.0 % Salidroside | Not specified | Not calculated |
| Capsicum annuum Source : Fruit | 8.0 milligramme | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piperine | 1.67 milligramme | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 8.23 milligramme | 24,690 µg |
| Chrome Source : Picolinate de chrome (III) | 100.0 microgrammes | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Croscarmellose de sodium, phosphate de dicalcium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Aids in the muscle recovery process by reducing muscle tissue damage associated with a resistance training regimen. Helps support muscle tissue repair in individuals involved in resistance training. Source of antioxidants. Workout supplement. Athletic support. Source of (an) amino acid(s) involved in muscle protein synthesis. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80083048
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.